Table 3.

Disease Distribution and Therapeutic effect of Drug patients.

Indication	Cases	Proportion, %	Efficiency, %	Hb/(g·L−1)			P	Hct/%		P
				Before	After			Before	After
Indications	20266	67.2	48.8	88.84 ± 20.53	101.4 ± 18.39	<0.05		0.27 ± 0.06	0.30 ± 0.05	<0.05
Anemia caused by renal failure	10896	36.1	43.5	83.96 ± 17.50	95.47 ± 14.49	<0.05		0.25 ± 0.05	0.29 ± 0.04	<0.05
Dialysis	967	3.2	43.1	83.04 ± 18.63	93.97 ± 14.77	<0.05		0.25 ± 0.05	0.28 ± 0.05	<0.05
Non-Dialysis	9929	32.9	43.6	84.05 ± 17.39	95.62 ± 14.46	<0.05		0.25 ± 0.05	0.29 ± 0.04	<0.05
Anemia caused by chemotherapy for non-bone marrow malignant tumors	3040	10.1	40.2	86.73 ± 0.05	97.11 ± 16.78	<0.05		0.26 ± 0.05	0.29 ± 0.05	<0.05
Perioperative erythrocyte mobilization	6330	20.9	–	97.38 ± 23.46	112.52 ± 0.06	<0.05		0.29 ± 0.07	0.34 ± 0.06	<0.05
Off-label	9886	32.8	50.7	87.21 ± 22.56	105.75 ± 20.54	<0.05		0.26 ± 0.07	0.32 ± 0.06	<0.05
Tumor associated anemia (non-chemotherapy)	8003	26.5	62.1	89.86 ± 22.61	107.18 ± 20.48	<0.05		0.27 ± 0.07	0.34 ± 0.70	<0.05
Chronic disease anemia	1653	5.5	74.0	76.02 ± 18.29	99.70 ± 19.34	<0.05		0.23 ± 0.06	0.30 ± 0.06	<0.05
Hemorrhagic anemia	150	0.5	73.3	73.1 ± 19.43	95.69 ± 18.11	<0.05		0.22 ± 0.06	0.29 ± 0.05	<0.05
Neonatal anemia	23	0.08	73.9	97.22 ± 20.20	134.39 ± 25.99	<0.05		0.29 ± 0.06	0.40 ± 0.08	<0.05
Other	57	0.2	66.7	78.38 ± 11.83	83.13 ± 14.59	<0.05		0.24 ± 0.04	0.25 ± 0.05	<0.05
Total	30152	100	53.1	88.36 ± 21.31	102.96 ± 19.28	<0.05		0.26 ± 0.06	0.31 ± 0.06	<0.05